Primer: Measuring the effects of treatment in clinical trials

Nature Clinical Practice Rheumatology

Volumn 3, Issue 5, 2007, Pages 291-297

  Ward, Michael M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; COMPARATIVE STUDY; DATA ANALYSIS; EXPERIMENTAL DESIGN; HYPOTHESIS; METHODOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; WELFARE;

CLINICAL MEDICINE; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 34248152733     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0478     Document Type: Review

References (29)

1. Friedman LM et al. (1996) Fundamentals of clinical trials, edn 2. St Louis: Mosby-Yearbook
2. Spilker B (1991) Guide to clinical trials. Philadelphia: Lippincott, Williams and Wilkins
3. Chow SC and Lui J (1998) Design and analysis of clinical trials. New York: John Wiley and Sons
4. Guyatt GH et al. (1993) Users' guide to the medical literature. II: How to use an article about therapy or preveAtion. A: are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 270: 2598-2601
5. Moher D et al. (2001) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285: 1987-1991
6. Prentice RL (1989) Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8: 431-440
7. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95
8. Weir CJ and Walley RJ (2006) Statistical evaluation of biomarkers as surrogate endpoints: A literature review. Stat Med 25: 183-203
9. Felson DT et al. (1990) Time for change in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum 33: 140-149
10. Forrow L et al. (1992) Absolutely relative: How research results are summarized can affect treatment decisions. Am J Med 92: 121-124
11. Rosenthal R (1991) Meta-analytic Procedures for Social Research, edn 2. Newbury Park: Sage Publications
12. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences edn 2. Hillsdale: Lawrence Erlbaum
13. Liang MH et al. (1990) Comparisons of five health status instruments for orthopedic evaluation. Med Care 28: 632-642
14. Cook RJ and Sackett DL (1995) The number needed to treat: A clinically useful measure of treatment effect. BMJ 310: 452-454
15. Browner WS et al. (2001) Getting ready to estimate sample size: hypotheses and underlying principles. In Designing clinical research: an apidemiologic approach, edn 2, 51-64 (Eds Hulley SB et al.) Philadelphia: Lippincott, Williams and Wilkins
16. Guyatt GH et al. (1998) Interpreting treatment effects in randomized trials. BMJ 316: 690-693
17. Beaton DE et al. (2001) Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol 28: 400-405
18. Browner WS et al. (2001) Estimating sample size and power: The nitty-gritty. In Designing clinical research: An epidemiologic approach, edn 2, 65-91 (Eds Hulley SB et al.) Philadelphia: Lippincott, Williams and Wilkins
19. Lenth RV (2006) Java applets for power and sample size [http://www.stat.uiowa.edu/~rlenth/Power] (accessed 7 May 2006)
20. Piaggio G et al. (2006) Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 295: 1152-1160
21. D'Agostino RB Sr et al. (2003) Non-inferiority trials: Design concepts and issues - the encounters of academic consultants in statistics. Stat Med 22: 169-186
22. Greene WL et al. (2000) Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med 132: 715-722
23. El-Masri MM and Fox-Wasylyshyn SM (2005) Missing data: An introductory conceptual overview for the novice researcher. Can J Nurs Res 37: 156-171
24. Garrett AD (2003) Therapeutic equivalence: Fallacies and falsification. Stat Med 22: 741-762
25. Hollis S and Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 319: 670-674
26. DeMets DL and Califf RM (2002) Lessons learned from recent cardiovascular clinical trials: Part I. Circulation 106: 746-751
27. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (online 5 February 1998) ICH Harmonised Tripartite Guideline. Statistical Principles for Clinical Trials E9 [www.ich.org/LOB/media/MEDIA485.pdf] (accessed 3 May 2006)
28. Guyatt GH et al. (1994) Users' guide to the medical literature. II: How to use an article about therapy or preveWtion. B: what were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 271: 59-63
29. Hayward RA et al. (2005) Reporting clinical trial results to inform providers, payers, and consumers. Health Aff 24: 1571-1581